Genmab A/S

NASDAQ: GMAB · Real-Time Price · USD
23.29
0.31 (1.35%)
At close: Aug 15, 2025, 3:59 PM
23.28
-0.02%
After-hours: Aug 15, 2025, 07:09 PM EDT

Genmab A/S Balance Sheet Statement

Financials in DKK. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
1.62B 9.86B 6.34B 4.33B 14.67B 14.87B 14.27B 10.87B 12.29B 9.89B 10.38B 9.82B 9.07B 8.96B 8.73B 9.48B 7.89B
Short-Term Investments
1.61B 11.24B 10.98B 11.4B 14.91B 13.27B 13.25B 14.01B 12.26B 12.43B 13.41B 11.8B 10.92B 10.38B 10.01B 8.4B 10.19B
Long-Term Investments
30M 228M 189M 196M 153M 134M 156M 183M 140M 133M 155M 201M 239M 371M 587M 753M 905M
Other Long-Term Assets
8M 52M 60M 77M 63M 62M 37M 31M 43M 48M 39M 66M 27M 27M 33M 33M 32M
Receivables
799M 6.69B 6.31B 6.17B 4.68B 4.95B 5.43B 4.81B 3.2B 5.71B 4.95B 3.88B 2.85B 3.37B 3.21B 2.43B 1.85B
Inventory
12M 62M 71M 36M 106M 57M 70M 51M -488M -143M n/a n/a -341M -31M n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a n/a n/a n/a 124M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
4.04B 27.85B 23.7B 21.94B 34.37B 33.14B 33.03B 29.75B 28.23B 28.38B 28.74B 25.49B 23.18B 22.74B 21.95B 20.3B 19.94B
Property-Plant & Equipment
271M 1.89B 1.8B 1.88B 1.86B 1.64B 1.65B 1.63B 1.6B 1.32B 1.29B 1.24B 975M 975M 957M 919M 842M
Goodwill & Intangibles
2.11B 14.88B 13.91B 14.53B 23M 101M 115M 129M 132M 146M 200M 216M 234M 254M 275M 297M 317M
Total Long-Term Assets
2.55B 17.96B 15.96B 16.68B 2.31B 2.15B 2.21B 2.23B 2.16B 1.9B 1.95B 1.99B 1.74B 1.89B 2.03B 2.18B 2.27B
Total Assets
6.59B 45.81B 39.66B 38.62B 36.68B 35.29B 35.24B 31.98B 30.39B 30.28B 30.69B 27.48B 24.91B 24.63B 23.98B 22.48B 22.21B
Account Payables
n/a n/a n/a n/a n/a n/a n/a n/a 1.83B 1.72B n/a n/a 1.25B 350M n/a n/a n/a
Deferred Revenue
6M 24M 39M 33M 33M 33M 33M 33M 33M 33M 33M 26M 26M 26M 26M 26M 26M
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 39M 32M n/a 860M n/a n/a n/a
Total Current Liabilities
756M 5.31B 4.58B 4.36B 2.76B 2.48B 2.9B 1.99B 1.96B 1.82B 2.99B 1.94B 1.34B 1.57B 1.83B 1.35B 1.29B
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
5M 30M 29M 28M 26M 515M 514M 29M 509M 491M 491M 496M 500M 500M 496M 496M 496M
Total Long-Term Liabilities
534M 3.81B 3.15B 3.29B 1.42B 1.2B 1.22B 1.23B 1.25B 1.01B 1.04B 1.05B 856M 863M 870M 880M 822M
Total Liabilities
1.29B 9.11B 7.74B 7.65B 4.18B 3.68B 4.13B 3.22B 3.2B 2.84B 4.03B 2.99B 2.19B 2.43B 2.7B 2.23B 2.12B
Total Debt
143M 1.03B 987M 1.02B 1.01B 770M 793M 803M 829M 597M 629M 634M 416M 425M 437M 443M 378M
Common Stock
10M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M 66M
Retained Earnings
3.54B 23.55B 19.62B 18.13B 19.8B 19.02B 18.45B 16.16B 14.67B 14.97B 14.3B 12.24B 10.51B 10.02B 9.14B 8.16B 8.02B
Comprehensive Income
-213M 490M -346M 234M 108M 60M 142M 112M 117M 98M 151M 110M 97M 81M 84M 82M 95M
Shareholders Equity
5.3B 36.7B 31.92B 30.97B 32.5B 31.61B 31.11B 28.75B 27.19B 27.44B 26.66B 24.48B 22.72B 22.2B 21.29B 20.25B 20.09B
Total Investments
1.64B 11.47B 11.16B 11.6B 15.07B 13.46B 13.41B 14.19B 12.4B 12.56B 13.57B 12B 11.16B 10.75B 10.6B 9.15B 11.1B